Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
57.9M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
50.2M
-
Shares change
-
+3.23M
-
Total reported value, excl. options
-
$2.77B
-
Value change
-
+$171M
-
Put/Call ratio
-
1
-
Number of buys
-
100
-
Number of sells
-
-85
-
Price
-
$55.19
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q2 2024
205 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q2 2024.
Arcellx, Inc. - COMMON STOCK (ACLX) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.2M shares
of 57.9M outstanding shares and own 86.79% of the company stock.
Largest 10 shareholders include FMR LLC (6.49M shares), PERCEPTIVE ADVISORS LLC (3.89M shares), Paradigm Biocapital Advisors LP (3.85M shares), NEA Management Company, LLC (3.75M shares), BlackRock Inc. (3.52M shares), SR One Capital Management, LP (2.35M shares), VANGUARD GROUP INC (2.3M shares), JANUS HENDERSON GROUP PLC (1.9M shares), STATE STREET CORP (1.76M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.63M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.